Market Currents
YM BioSciences (YMI) says its buyout by a wholly owned subsidiary of Gilead Sciences (GILD...
-
Friday, January 18, 3:43 PM ETYM BioSciences (YMI) says its buyout by a wholly owned subsidiary of Gilead Sciences (GILD +0.8%) has been endorsed by proxy advisory firms Institutional Investor Services and Glass, Lewis & Co. ISI says the all-cash deal offers a satisfactory premium, while Glass Lewis also notes that the YMI board of directors conducted a reasonable review of strategic alternatives available to the company prior to entering into the proposed agreement.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
